GLP1R and coronary artery disorder: We found no evidence for an association of genetically proxied GLP1R agonism with coronary artery disease risk (OR per 1 mmol/mol decrease in glycated hemoglobin, 1.02; 95% CI, 0.89–1.16; P=0.80).